Beni-Suef University Journal of Basic and Applied Sciences最新文献

{"title":"Comparative study between effect of preoperative multimodal analgesia and pregabalin as unimodal analgesia in reduction of postoperative opioids consumption and postoperative pain in laparoscopic cholecystectomy","authors":"Yassmin M. Kamal,&nbsp;Engy A. Wahsh,&nbsp;Hisham A. Abdelwahab,&nbsp;Walied A. ElBaz,&nbsp;Hazem A. Hussein,&nbsp;Hoda M. Rabea","doi":"10.1186/s43088-024-00562-1","DOIUrl":"10.1186/s43088-024-00562-1","url":null,"abstract":"<div><h3>Background</h3><p>Laparoscopic cholecystectomy is a popular abdominal surgery and the most common problem for patients undergoing laparoscopic cholecystectomy is the postoperative pain, and associated side effects due to opioids use for pain management and multimodal analgesia is suggested to reduce postoperative pain and need for postoperative opioids. This controlled clinical trial compares the effects of multimodal analgesia and pregabalin as unimodal analgesia on postoperative pain management, postoperative opioids consumption, and reduction of opioids accompanied adverse effects in patients undergoing laparoscopic cholecystectomy where large multicenter studies evaluating specific analgesic combinations are lacking.</p><h3>Method</h3><p>This comparison randomized controlled trial between multimodal analgesia approach and pregabalin as unimodal analgesia included 95 laparoscopic cholecystectomy patients that were randomly allocated to three groups using a simple randomization method where multimodal and pregabalin groups included 30 patients in each and the drugs was administered orally one hour before the incision and control group included 35 patients that did not receive any preoperative analgesia. Multimodal analgesic therapy included acetaminophen 1 g, pregabalin 150 mg and celecoxib 400 mg while pregabalin group received pregabalin 150 mg only.</p><h3>Results</h3><p>Multimodal group showed a significantly lower need for total opioid analgesics mean ± SD (1.33 ± 1.918) as compared to the control group mean ± SD (3.31 ± 2.784) with p-value 0.014. Pregabalin and multimodal groups showed significantly lower postoperative visual analogue scale used for pain assessment mean ± SD (3.50 ± 2.543) and mean ± SD (3.70 ± 2.231), respectively, compared to the control group mean ± SD (5.89 ± 2.857) with p-value 0.001.</p><h3>Conclusion</h3><p>Multimodal analgesia reduced postoperative opioids consumption more than pregabalin alone when used preoperatively in laparoscopic cholecystectomy and consequently reduced opioids associated adverse effects, but they have the same efficacy in reducing postoperative pain, so pregabalin can be used alone preoperatively in patients with contraindications for using some analgesics included in multimodal analgesia protocol. The study was registered retrospectively in clinical trials; Trial registration ID: NCT05547659.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00562-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142579412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The potential of fibroblast growth factor-21 and adiponectin as diagnostic biomarkers for type 2 diabetes mellitus: differential levels in response to treatments","authors":"Madleen Nabeel Al-Qusous,&nbsp;Rami Dwairi,&nbsp;Rasha Mohamed Hussein","doi":"10.1186/s43088-024-00571-0","DOIUrl":"10.1186/s43088-024-00571-0","url":null,"abstract":"<div><h3>Background</h3><p>Diabetes mellitus (DM) is a global epidemic disease affecting millions each year. Recent studies have suggested novel biomarkers that are linked to DM. This study aimed to measure the levels of fibroblast growth factor-21 (FGF-21) and adiponectin in the blood of patients with type 2 DM and to assess the variations in their levels in response to the type of treatments. The possible correlations with several biochemical parameters and the diagnostic potential of FGF-21 and adiponectin as biomarkers for DM were also investigated. Eighty subjects were classified into control, Type 2 DM patients who were treated with metformin, Type 2 DM patients who were treated with metformin + oral hypoglycemic agents (OHAs), and Type 2 DM patients who were treated with insulin + metformin + OHAs.</p><h3>Results</h3><p>The metformin + OHAs group and the insulin + metformin + OHAs group had higher levels of FGF-21 when compared to the control group. The metformin + OHAs also had significantly higher adiponectin levels when compared to the control or metformin groups. The serum levels of FGF-21 in the diabetic subjects were negatively correlated with LDL, direct bilirubin, albumin, and insulin levels and positively correlated with the duration of DM. However, the serum levels of adiponectin in the diabetic subjects were negatively correlated with weight while positively correlated with potassium levels. Remarkably, FGF-21 and adiponectin were effective biomarkers for diagnosing DM with a specificity of 100% and 90% and sensitivity of 52.3% and 64.5%, respectively.</p><h3>Conclusion</h3><p>These findings suggest that FGF-21 and adiponectin play crucial roles in DM diagnosis and prognosis and that their levels change depending on the treatment type.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00571-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142540720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the impact of brucellosis on maternal and child health: transmission mechanisms, patient effects, and current trends in drug use and resistance: a scoping review","authors":"Tran Xuan Ngoc Huy","doi":"10.1186/s43088-024-00569-8","DOIUrl":"10.1186/s43088-024-00569-8","url":null,"abstract":"<div><h3>Background</h3><p>While often unrecognized, brucellosis, a significant zoonotic disease, silently endangers the health of mothers and children worldwide. This scoping review sheds light on transmission pathways, maternal–fetal consequences, and treatment hurdles, specifically considering maternal and child health concerns.</p><h3>Method</h3><p>To comprehensively grasp brucellosis in mothers and children, we systematically scoured electronic databases (DOAJ, Google Scholar, PubMed, and Semantic Scholar) for studies published after 2005. Our search included experimental studies (both randomized controlled clinical trials and quasi-experimental), analytical observations, descriptive reports, qualitative papers, and existing systematic reviews. All retrieved data were then charted and processed following Arksey and O'Malley's established framework for scoping reviews.</p><h3>Result</h3><p>Twenty-five studies spanning varied regions and methodologies met inclusion criteria. Key findings demonstrate that zoonotic brucellosis acquisition from livestock exposures among vulnerable maternal groups accounts for up to 70% of cases. Vertical transmission from mother to child during pregnancy, delivery, or breastfeeding was reported in 15–20% of cases. Substantial risks of miscarriage (25%), preterm birth (20%), hepatosplenomegaly (10%), febrile illness (30%), and possible long-term complications were documented. Treatment success rates using combination antibiotic therapy were reported to be as high as 98%, though emerging antibiotic resistance patterns challenge effective treatment, with 25% of Brucella isolates resistant to rifampin and 51% resistant to both trimethoprim-sulfamethoxazole and streptomycin.</p><h3>Conclusion</h3><p>This review reveals the alarming yet hidden toll brucellosis takes on maternal–fetal pairs and breastfeeding. In regions battling this endemic disease, tailored education, upgraded diagnostic tools, prompt antibiotic therapy, responsible antimicrobial stewardship, and One Health collaborations offer crucial pathways to shield mothers and children from its harmful consequences. Continued research will pave the way for even better solutions to alleviate this complex zoonosis, particularly for vulnerable populations.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00569-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142540756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction: Synthesis and efficacy of cinnamon oil formulations and their sustainable release against common house mosquito larvae","authors":"Hesham A. Mahran,&nbsp;Shawky M. Aboelhadid,&nbsp;Khaled M. Hassan","doi":"10.1186/s43088-024-00564-z","DOIUrl":"10.1186/s43088-024-00564-z","url":null,"abstract":"","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00564-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142524397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment‏","authors":"Doaa M. Anwar,&nbsp;Heidy Y. Hedeya,&nbsp;Sama H. Ghozlan,&nbsp;Basma M. Ewas,&nbsp;Sherine N. Khattab","doi":"10.1186/s43088-024-00566-x","DOIUrl":"10.1186/s43088-024-00566-x","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;p&gt;Nanoparticle-mediated drug delivery aims to target specific cells, addressing the challenge that many drugs lack the necessary properties to reach their intended targets effectively. Lipid-based nanocarriers considered as a promising drug delivery due to their biocompatibility and ability to encapsulate various drugs. Surface modifications, including the attachment of polyethylene glycol for stability and the conjugation of targeting ligands (e.g., antibodies, peptides) for specific delivery, play a crucial role in enhancing the interaction of these nanocarriers with biological environments. These modifications improve cellular uptake and targeted delivery, thereby increasing therapeutic efficacy and reducing side effects. This review will explore various surface modification techniques and their impact on the performance of lipid nanocarriers in drug delivery.&lt;/p&gt;&lt;h3&gt;Main body&lt;/h3&gt;&lt;p&gt;Lipid-based nanodelivery platforms have garnered significant interest due to their notable characteristics, including their ability to accommodate high drug loads, reduced toxicity, improved bioavailability, and compatibility with biological systems, stability within the gastrointestinal environment, controlled release capabilities, streamlined scaling up processes, and simplified validation procedures. Targeted lipid-based nanocarriers represent a significant advancement over non-targeted counterparts in cancer therapy. Unlike non-targeted systems, which distribute drugs indiscriminately throughout the body, targeted lipid-based nanocarriers can be engineered with ligands or antibodies to specifically recognize and bind to tumor-associated markers, enabling precise drug delivery to cancer cells. This targeted approach enhances therapeutic efficacy while minimizing adverse effects on healthy tissues, thereby offering a promising strategy for improving the outcomes of cancer treatment.&lt;/p&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;The authors in this review provide an overview of preclinical research on diverse lipid-based nanocarriers, such as liposomes, solid lipid nanocarriers, and lipid polymer hybrid nanoparticles. The customization of these carriers using various surface modifiers is discussed, including folic Acid, peptides, polysaccharides, transferrin, and antibodies. Surface-modified nanocarriers offer regulated discharge, improved penetration capability, and precise drug conveyance. This work compiles recent instances of emerging surface-modified lipid-based nanocarrier systems and their applications, sourced from existing literature. Novel approaches to surface engineering of these nanocarriers, aimed at enhancing their specificity and efficacy in targeted drug delivery, were discussed. Key advancements in this field, such as improved targeting mechanisms and significant therapeutic outcomes demonstrated in preclinical studies, were highlighted. Additionally, critical gaps that require attention include long-term stability, biocompatibility, scalabl","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00566-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142518780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction: Synergistic strategies for cancer treatment: leveraging natural products, drug repurposing and molecular targets for integrated therapy","authors":"Indira Mikkili,&nbsp;Jagadish Kumar Suluvoy,&nbsp;Jesse Joel Thathapudi,&nbsp;Krupanidhi Srirama","doi":"10.1186/s43088-024-00567-w","DOIUrl":"10.1186/s43088-024-00567-w","url":null,"abstract":"","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00567-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142518514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advancements of biomaterials in oral tissue engineering: past, present, and future","authors":"Miao Sun,&nbsp;Like Tang,&nbsp;Xiaofu Yang,&nbsp;Jingyi Lu,&nbsp;Huihui He,&nbsp;Jun Lin,&nbsp;Yong He,&nbsp;Mengfei Yu","doi":"10.1186/s43088-024-00538-1","DOIUrl":"10.1186/s43088-024-00538-1","url":null,"abstract":"<div><h3>Background</h3><p>The deformation of oral and maxillofacial region leads to not only the damage of morphology and function, but also a series of aesthetic and psychological problems, severely affecting the quality of life of patients. Oral tissue engineering refers to developing biomaterials for repair or regeneration, with the application of tissue engineering technologies. This has become an area of increasing prominence. Current biologically inert materials are insufficient to fulfill clinical requirements. Therefore, tissue-engineered biomaterials with bioactive, even bionic properties are desperately needed.</p><h3>Main body</h3><p>The complexity of the anatomy and the diversity of tissue types of oral and maxillofacial region pose great challenges to the regeneration, in the aspects of both biomaterials and manufacturing technologies. Biomaterials in clinical practice or research have evolved from natural materials to synthetic materials, from homogeneous materials to multiple composite materials. And now composite materials have increasingly demonstrated their advantages in terms of physicochemical and biological properties over conventional materials. In terms of manufacturing, traditional coating, sintering, and milling technologies can no longer satisfy the requirements for high-precision bionic structures of oral-tissue-engineering biomaterials. Scientists have turned to biofabrication technologies such as microfluidics and additive manufacturing.</p><h3>Short conclusion</h3><p>This review aims to summarize the noteworthy advancements made in biomaterials of oral tissue engineering. We outlined the current biomaterials and manufacturing technologies and focused on various applications of these materials that may be connected to clinical treatment and research. We also suggested the future direction of development for biomaterials in oral tissue engineering. In future, biomaterials characterized by precision, functionalization, and individualization will be manufactured through digital, microfluidic, and 3D printing technologies.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00538-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142397577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Copeptin as an inflammatory marker in diagnosis and prognosis of neonatal sepsis","authors":"Amna G. Mabrouk,&nbsp;Sameh S. Fahmey,&nbsp;Jhon B. Naguib,&nbsp;Rehab M. Abd-Elkareem,&nbsp;Yasmen A. Mohamed","doi":"10.1186/s43088-024-00563-0","DOIUrl":"10.1186/s43088-024-00563-0","url":null,"abstract":"<div><h3>Background</h3><p>Copeptin is an immediate biomarker of individual stress response; many life-threatening diseases are causing a high elevation of its concentration in plasma, such as myocardial infarction and cardiovascular shock. Moreover, copeptin is a promising marker in sepsis. We aimed to evaluate copeptin as a diagnostic and prognostic marker in neonatal sepsis for the early initiation of appropriate therapy and the prediction of mortality. A prospective case-control study involved 237 neonates (165 cases had neonatal sepsis, and 72 served as controls). Cases were admitted to the neonatal intensive care unit (NICU) and followed up for symptoms and signs of sepsis confirmed by laboratory data: complete blood count (CBC), c-reactive protein (CRP), and cultures. Serum copeptin level by the enzyme-linked immunosorbent assay (ELISA) was measured for all included neonates. We observed that the copeptin level was significantly higher in cases than control (3.51 ± 1.4, 1.61 ± 0.51 pmol/liter, respectively). The cut-off value of copeptin at which we can discriminate between cases and controls was above 2.065 pmol/liter. Among cases, copeptin was higher in early-onset sepsis (EOS) than late-onset sepsis (LOS) neonates, and there was a significant correlation between its level and all the following: age at admission, birth weight, gestational age, history of perinatal asphyxia, maternal chorioamnionitis, and premature rupture of membrane (PROM). Also, copeptin was strongly associated with CRP level and the poor prognosis of patients. Copeptin can predict the death of cases at a cut-off value above 2.995 pmol/liter.</p><h3>Conclusion</h3><p>Serum copeptin level can be used as a diagnostic and prognostic marker in neonatal sepsis.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00563-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High levels of bisphenol A among infertile men can impair spermatogenesis by oxidative stress and elevated levels of microRNA-337","authors":"Manar A. Ahmad,&nbsp;Nashaat Nabil Ismail,&nbsp;Sherien S. Ghaleb,&nbsp;Dalia Abd Elwhab Hassan,&nbsp;Reham S. Al-Fakharany,&nbsp;Mohammed M. Ghoneim,&nbsp;Amany M. Ahmed,&nbsp;Amr Mohamed Lotfy,&nbsp;Ahmed Fathy Mohamed AboSief","doi":"10.1186/s43088-024-00559-w","DOIUrl":"10.1186/s43088-024-00559-w","url":null,"abstract":"<div><h3>Background</h3><p>Studies have shown that Bisphenol A may interfere with the process of spermatogenesis and result in a decrease in the quality of semen. Nevertheless, the fundamental processes remain unclear. This study was done to investigate the connections between exposure to Bisphenol A, spermatogenesis with microRNA-337, and malondialdehyde in infertile men.</p><h3>Methods</h3><p>This study was a case–control study on 73 participants. Infertile group (1a): azoospermia (<i>n</i> = 16), infertile group (1b): oligozoospermia (<i>n</i> = 22), and control group (2): normospermic (<i>n</i> = 35) were enrolled in this study. Full history, local examination, semen analysis, and urine and blood samples were taken from all participants. Urinary Bisphenol A, malondialdehyde, and serum microRNA-337 were measured.</p><h3>Results</h3><p>The mean Bisphenol A level in azoospermia group shows statistically significant increase comparing to fertile control group. The mean microRNA-337 level in oligozoospermia and azoospermia group shows statistically significant increase comparing to fertile controls. The mean malondialdehyde level in infertility groups shows statistically significant increase comparing to fertile control group. No linear correlations were recorded between Bisphenol A levels with semen quality parameters, hormonal profile, and microRNA-337.</p><h3>Conclusion</h3><p>While there is no significant change in the levels of Bisphenol A between normal fertile males and infertile males with oligozospermia, a significant elevation in the BPA level was observed in infertile males with azoospermia. A significant upregulation of the miRNA-337 gene expression in infertile males either oligozospermia or azoospermia was also observed. In addition, lipid peroxidation as evident by the significant elevation of MDA levels was marked among infertile patients.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00559-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A preliminary study on decomposition and seasonality of insect succession of decomposing rabbit carcasses at El-Sharkia Governorate, Egypt","authors":"El-Sayed H. Shaurub,&nbsp;Abeer M. Salem,&nbsp;Eman E. Zaher","doi":"10.1186/s43088-024-00561-2","DOIUrl":"10.1186/s43088-024-00561-2","url":null,"abstract":"<div><h3>Background</h3><p>Studying insect succession on carcasses is important in estimating the postmortem interval. This study aims to identify the decomposition stages of decomposing rabbit carcasses and to find out the relationship between seasonal variations and abundance of insects colonizing rabbit carcasses at El-Sharkia Governorate, Egypt.</p><h3>Methods</h3><p>Three domestic rabbits (weighing 1300 g each) were killed by a sharp knife. The carcasses were exposed to the sun, left to decompose and inspected twice daily at 6-h intervals to collect insects. Maggots were collected and reared.</p><h3>Results</h3><p>The rabbit carcasses underwent four decomposition stages: fresh, bloat, decay and dry stages. The identified families and their respective collected species included three dipteran families: Calliphoridae (<i>Lucilia sericata, Chrysomya megacephala,</i> and <i>Chrysomya albiceps</i>), Sarcophagidae (<i>Sarcophaga argyrostoma</i>) and Muscidae (<i>Musca domestica</i> and <i>Synthesiomyia nudiseta</i>), three coleopteran families. Histeridae (<i>Saprinus semistriatus</i>), Cleridae (<i>Necrobia rufipes</i>) and Dermestidae (<i>Dermestes frischii</i> and <i>Attagenus gloriosus</i>) and three hymenopteran families: Chalcididae (<i>Brachymeria femorata</i>), Vespidae (<i>Vespa orientalis</i>) and Formicidae (<i>Monomorium sp.</i>). Carrion fauna was dominated by dipteran and coleopteran species, with calliphorid and sarcophagid flies found to play a significant role in carrion consumption process.</p><h3>Conclusion</h3><p>The succession pattern and decomposition rate were season dependent. The information collected may help establish the basic database for entomological forensic investigations in the future.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"13 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-024-00561-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}